Successful therapy confirmed for newborns with fatal metabolic disorder MoCD type A
The drug fosdenopterin/rcPMP considerably improves the chances of survival and developmental progress in infants with ...
Nature4 年
Targeting rare and metabolic diseases with transformative therapies
Rezolute, Inc, a clinical-stage biopharmaceutical company, is currently developing a novel CHI therapy to fill this need, along with therapies for other common metabolic disorders. Rezolute ...
Nature2 年
Pharmacologic duodenal exclusion: a novel therapy for metabolic diseases
“At Glyscend, our goal is to leverage the remarkable disease-modifying effects of metabolic surgery with a convenient, non-invasive, oral therapy,” said Ashish Nimgaonkar, President and CEO of ...
Business Wire19 天
Baszucki Group Announces Two Research Initiatives for Youth with Bipolar
Both programs are pioneering metabolic research with pediatric bipolar patients. These projects aim to develop ketogenic therapy programs and establish pilot data to fuel future randomized control ...
Medical Dialogues13 天
Ketogenic diet in bipolar disorder patients may improve mental and metabolic outcomes: Study
A new study published in the British Journal of Psychiatry Open revealed that people with bipolar disorder may benefit ...
The Manila Times3 天
Innovent Receives NMPA Breakthrough Therapy Designation for IBI363 (PD-1/IL-2α-bias ...
Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...